Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A

SSSE:600513
11.88
CNY
-0.31
(-2.54%)
4.31BMarket Cap

Total Valuation

CNY

As of September 30, 2026, Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A carries a market capitalization of 4.31B, placing it among publicly traded companies globally. Its enterprise value stands at 6.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.31B
Enterprise Value6.23B

Share Statistics

As of September 30, 2026, Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A has 285.46M shares outstanding.

Shares Outstanding285.46M

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio3.40
P/TBV Ratio6.66

Financial Position

As of September 30, 2026, Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

Current Ratio0.98
Quick Ratio0.12
Debt / Equity104.44

Financial Efficiency

These figures cover the twelve months ended September 30, 2026.

Employee Count2,131.00

Taxes

CNY

Over the twelve months ended September 30, 2026, Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A recorded 11.18M in income tax expense.

Income Tax11.18M

Stock Price Statistics

CNY

As of the close on November 17, 2026, Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A's stock has declined approximately 47.89% over the past 52 weeks. The 50-day moving average sits at 14.25, while the 200-day moving average is 18.01.

52-Week Price Change-47.89%
50-Day Moving Average14.25
200-Day Moving Average18.01

Balance Sheet

CNY

As of September 30, 2026, Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A holds 227.72M in cash and equivalents against 1.75B in total debt, resulting in a net debt position of 1.20B. Total book value stands at 1.27B, with working capital of -42.53M providing operational flexibility.

Cash & Cash Equivalents227.72M
Total Debt1.75B
Net Debt1.20B
Equity (Book Value)1.27B
Book Value Per Share4.44
Working Capital-42.53M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-151.40M

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A paid dividends of 0.19 per share.

Dividend Per Share0.19

Stock Splits

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A's most recent stock split took place on May 19, 2017 with a 10:13 split ratio.

Last Split Date5/19/2017
Split Ratio10:13